BIN1 is a novel MYC–interacting protein with features of a tumour suppressor (original) (raw)

References

  1. Cole, M.D. The myc oncogene: Its role in transformation and differentiation. Annu. Rev. Genet. 20, 361–384 (1986).
    Article CAS Google Scholar
  2. Evan, G.I. & Littlewood, T.D. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3, 44–49 (1993).
    Article CAS Google Scholar
  3. Packham, G. & Cleveland, J. c-Myc and apoptosis. Biochim. Biophys. Acta 1242, 11–28 (1995).
    PubMed Google Scholar
  4. Henriksson, M. & Lüscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109–182 (1996).
    Article CAS Google Scholar
  5. Eilers, M., Picard, D., Yamamoto, K.R. & Bishop, J.M. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66–68 (1989).
    Article CAS Google Scholar
  6. Heikkila, R. et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 328, 445–448 (1987).
    Article CAS Google Scholar
  7. Holt, J.T., Redner, R.L. & Nienhuis, A.W. An oligomer complementary to c-myc mRNA inhibits prolieration of HL-60 promyeloctic cells and induces differentiation. Mol. Cell. Biol. 8, 963–973 (1988).
    Article CAS Google Scholar
  8. Sklar, M.D. et al. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol. Cell. Biol. 11, 3699–3710 (1991).
    Article CAS Google Scholar
  9. Sawyers, C.L., Callahan, W. & Witte, O.N. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70, 901–10 (1992).
    Article CAS Google Scholar
  10. Hanson, K.D., Shichiri, M., Follansbee, M.R. & Sedivy, J.M. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol. 14, 5748–5755 (1994).
    Article CAS Google Scholar
  11. Askew, D.S., Ashmun, R.A., Simmons, B.C. & Cleveland, J.L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915–22 (1991).
    CAS Google Scholar
  12. Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 (1992).
    Article CAS Google Scholar
  13. Meichle, A., Philipp, A. & Eilers, M. The functions of Myc proteins. Biochim Biophys Acta 1114, 129–146 (1992).
    CAS PubMed Google Scholar
  14. Stone, J. et al. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7, 1697–1709 (1987).
    Article CAS Google Scholar
  15. Kato, G.J., Barrett, J., Villa-Garcia, M. & Dang, C.V. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10, 5914–5920 (1990).
    Article CAS Google Scholar
  16. Gupta, S., Seth, A. & Davis, R.J. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90, 3216–3220 (1993).
    Article CAS Google Scholar
  17. Seth, A., Gupta, S. & Davis, R.J. Cell cycle regulation of the c-Myc transcriptional activation domain. Mol. Cell. Biol. 13, 4125–4136 (1993).
    Article CAS Google Scholar
  18. Lutterbach, B. & Hann, S.R. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol. 14, 5510–5522 (1994).
    Article CAS Google Scholar
  19. Hoang, A.T. et al. A link between increase transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15, 4031–4042 (1995).
    Article CAS Google Scholar
  20. Li, L., Nerlov, C., Prendergast, G., MacGregor, D. & Ziff, E.B. c-Myc activates and represses target gene through the E-box Myc binding site and the core promoter region respectively. EMBO J. 13, 4070–4079 (1994).
    Article CAS Google Scholar
  21. Papas, T.S. & Lautenberger, J.A. Sequence curiosity in v-myc oncogene. Nature 318, 237 (1985).
    Article CAS Google Scholar
  22. Bhatia, K. et al. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genet. 5, 56–61 (1993).
    Article CAS Google Scholar
  23. Yano, T. et al. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene 8, 2741–8 (1993).
    CAS PubMed Google Scholar
  24. Gu, W., Bhatia, K., Magrath, I.T., Dang, C.V. & DallaFavera, R. Binding and suppresion of the myc transcriptional activation domain by p107. Science 264, 251–254 (1994).
    Article CAS Google Scholar
  25. Beijersbergen, R.L., Hijmans, E.M., Zhu, L. & Bernards, R. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13, 4080–4086 (1994).
    Article CAS Google Scholar
  26. Vojtek, A.B., Hollenberg, S.M. & Cooper, J.A. Mammalian ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205–214 (1993).
    Article CAS Google Scholar
  27. Pulverer, B.J. et al. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9, 59–70 (1994).
    CAS PubMed Google Scholar
  28. Bianchi, M.W., Plyte, S.E., Kreis, M. & Woodgett, J.R. A Saccharomyces cerevisiae protein-serine kinase related to mammalian glycogen synthase kinase-3 and the Drosophila melanogaster gene shaggy product. Gene 134, 51–6 (1993).
    Article CAS Google Scholar
  29. Pawson, T. & Gish, G.D. SH2 and SH3 domains: from structure to function. Cell 71, 359–362 (1992).
    Article CAS Google Scholar
  30. Lichte, B., Veh, R.W., Meyer, H.E. & Kilimann, M.W. Amphiphysin, a novel protein associated with synaptic vesicles. EMBO J. 11, 2521–2530 (1992).
    Article CAS Google Scholar
  31. Folli, F. et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N. Engl. J. Med. 328, 546–51 (1993).
    Article CAS Google Scholar
  32. Brown, R.H. in Principles of Internal Medicine (eds Isselbacher, K.J.) 1878–1882 (McGraw-Hill, New York, 1994).
    Google Scholar
  33. Bauer, F., Urdaci, M., Aigle, M. & Crouzet, M. Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns. Mol. Cell. Biol. 13, 5070–5084 (1993).
    Article CAS Google Scholar
  34. Land, H., Parada, L.F. & Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596–602 (1983).
    Article CAS Google Scholar
  35. Ruley, H.E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602–606 (1983).
    Article CAS Google Scholar
  36. Rao, L. et al. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89, 7742–7746 (1992).
    Article CAS Google Scholar
  37. Leder, A., Pattengale, P.K., Kuo, A., Stewart, T.A. & Leder, P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45, 485–95 (1986).
    Article CAS Google Scholar
  38. Sinn, E. et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49, 465–75 (1987).
    Article CAS Google Scholar
  39. Berns, E.M. et al. c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res. 52, 1107–13 (1992).
    CAS PubMed Google Scholar
  40. Hehir, D.J., McGreal, G., Kirwan, W.O., Kealy, W. & Brady, M.P. c-myc oncogene expression: a marker for females at risk of breast carcinoma. J. Surg. Oncol. 54, 207–9 (1993).
    Article CAS Google Scholar
  41. Kreipe, H. et al. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Cancer Res. 53, 1956–61 (1993).
    CAS PubMed Google Scholar
  42. Watson, P.H., Safneck, J.R., Le, K., Dubik, D. & Shiu, R.P. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J. Natl. Cancer Inst. 85, 902–7 (1993).
    Article CAS Google Scholar
  43. David, C., McPherson, P.S., Mundigl, O. & de Camilli, P. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proc. Natl. Acad. Sci. USA 93, 331–335 (1996).
    Article CAS Google Scholar
  44. Gaubatz, S., Meichle, A. & Eilers, M. An E-box element localized in the first intron mediates regulation of the prothymosin α gene by c-myc. Mol. Cell. Biol. 14, 3853–3862 (1994).
    Article CAS Google Scholar
  45. Born, T., Frost, J., Schönthal, A., Prendergast, G.C. & Feramisco, J. c-Myc and oncogenic ras induce the cdc2 promoter. Mol. Cell. Biol. 14, 5741–5747 (1994).
    Article Google Scholar
  46. Bello-Fernandez, C., Packham, G. & Cleveland, J.L. The ornithine decarboxylase gene is a transcriptional target of c-MYC. Proc. Natl. Acad. Sci. USA 90, 7804–7808 (1993).
    Article CAS Google Scholar
  47. Sakamuro, D. et al. c-Myc induces apoptosis in epithelial cells by p53-dependent and p53-independent mechanisms. Oncogene 11, 2411–2418 (1995).
    CAS PubMed Google Scholar
  48. Negorev, D. et al. The Bin1 gene localizes to human chromsome 2q14 by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization. Genomics 33, 329–331 (1996).
    Article CAS Google Scholar
  49. Cher, M.L. et al. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56, 3091–3102 (1996).
    CAS PubMed Google Scholar
  50. Hayata, I. et al. Chromosomal aberrations observed in 52 mouse myeloid leukemias. Cancer Res. 43, 367–373 (1983).
    CAS PubMed Google Scholar
  51. Jahner, D. & Hunter, T. The _ras_-related gene _rho_B is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11, 3682–3690 (1991).
    Article CAS Google Scholar
  52. Murre, C., McCaw, P.S. & Baltimore, D. A new DMA-binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and Myc proteins. Cell 56, 777–783 (1989).
    Article CAS Google Scholar
  53. Prendergast, G.C., Lawe, D. & Ziff, E.B. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65, 395–407 (1991).
    Article CAS Google Scholar
  54. Niman, H.L. et al. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. USA 80, 4949–4953 (1983).
    Article CAS Google Scholar
  55. Kelekar, A. & Cole, M. Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes. Mol. Cell. Biol. 6, 7–14 (1986).
    Article CAS Google Scholar
  56. Prendergast, G.C., Hopewell, R., Gorham, B. & Ziff, E.B. Biphasic effect of Max on Myc transformation activity and dependence on N-and C-terminal Max functions. Genes Dev. 6, 2429–2439 (1992).
    Article CAS Google Scholar
  57. Chen, C. & Okayama, H. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752 (1987).
    Article CAS Google Scholar
  58. Harlow, E. & Lane, D. Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1988).
    Google Scholar
  59. Prendergast, G.C. & Ziff, E.B. Mbh1: A novel gelsolin/severin-related protein which binds actin in vitro and exhibits nuclear localization in vivo. EMBO J. 10, 757–766 (1991).
    Article CAS Google Scholar
  60. Prendergast, G.C. & Cole, M.D. Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol. Celt. Biol. 9, 124–134 (1989).
    Article CAS Google Scholar
  61. Shiozawa, M. et al. Synthesis of human gamma-glutamyl transpeptidase (GGT) during the fetal development of liver. Gene 87, 299–303 (1990).
    Article CAS Google Scholar
  62. Church, G.M. & Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81, 1991–1995 (1984).
    Article CAS Google Scholar
  63. Yamamoto, R., Li, X., Winter, S., Francke, U. & Kilimann, M.W. Primary structure of human amphiphysin, the dominant autoantigen of paraneoplastic Stiff-Man Syndrome, and mapping of its gene (AMPH) to chromosome 7p13–p14. Human Mol. Genet. 4, 265–268 (1995).
    Article CAS Google Scholar

Download references